Carlsbad
(760) 431-2273
Murrieta
(951) 600-9803
Ontario
(909) 947-3600
OPEN 24
HOURS
Invisible virus is being evaluated as the next generation of compassionate cancer cures
August 10, 2012



The investigative FOXNews journalists caught up with the clinicians, nurses and researchers at California Veterinary Specialists Angel Care Cancer Center to learn how an invisible virus is being evaluated as the next generation of compassionate cancer cures in dogs, cats and people. Angel Care Cancer Center, a separate but allied non-profit research organization, the Special Care Foundation for Companion Animals and the San Diego based company Genelux have teamed up to affirm the safety an efficacy of a new cancer killing virus. The therapy includes a modification of a virus that has been used worldwide to wipe out smallpox as a threat to human health. Families who bring their beloved pets with cancer to Angel Care seek the highest level of advanced yet gentle cancer care and novel, new therapies that are likely to become the therapies of the future. The purpose of the study is to determine the optimum way of treating these dogs with cancer while taking these results to develop new approaches to enhance the cure rates in children and adults.

The CVS Angel Care Cancer Center is a comprehensive cancer center that provides direct care for patients with cancer and their families. This team offers innovative clinical research to provide the very best diagnostics and treatments available to fight against cancer. They are a group of veterinarians, veterinary nurses, and human physicians that share a mutual philosophy: science may provide a cure, but compassionate care comes from the heart. The goal is to do everything possible to not only win the fight against cancer, but to ensure the treatment is healing, not hurting.


RELATED ARTICLES
CVS Angel Care Named Business of the Month for Canine Cancer Trials
Mar 19, 2014
MURRIETA, CALIF. — California Veterinary Specialists Angel Care Center (CVS Angel Care) was named March Business of the Month by Assemblywoman Melissa Melendez for the Center’s canine cancer clinical trials using Voyager, a new and revolutionary non-invasive anti-cancer medical device. “We are overjoyed to receive this award from Assemblywoman Melendez for our work to eliminate cancer in pets,” said Dr. Greg Ogilvie, founder of CVS Angel Care. “Voyager has the potential to save hundreds of thousands of lives and has given families of...
Nativis Voyager: New Groundbreaking Cancer Treatment
Feb 20, 2013
Dr. Ogilvie is directing a ground breaking canine clinical trial using a new and revolutionary non-invasive medical device called Voyager. "Voyager is just beginning its voyage as we are beginning the process of identifying the cancers its most effective to treat. It seems to have a broad spectrum of efficacy while being quite safe." The Voyager results are remarkable. Rapid and durable tumor response has been seen in many patients, resulting in partial and complete remissions. After one week of treatment, Voyager safely eliminated 90% of one..
UPDATE: Canine Lymphoma Trial at CVS Angel Care
Oct 13, 2014
We are in a process developing a new therapy for dogs with lymphoma that harnesses the immune system to destroy its own cancer. With appropriate therapy we are able to not only enhance and improve their quality of life but also extend that life and reduce the need for chemotherapy. This non-invasive, fully-funded study is one in which we take animals that have lymphoma and willing families who are excited about exploring new opportunities that will enhance and improve the quality of life of a pet with cancer. The veterinary health team...
CVS Advances New Therapy for Dogs with T Cell Lymphoma
Nov 19, 2014
Investigators from California Veterinary Specialists empowered by funding from the Special Care Foundation for Companion Animals, has worked with the discovery team led by Dr. Genevieve Hansen to develop a novel therapy for T-cell lymphoma in dogs. The veterinary oncologists and nurses at all three CVS hospitals (Murrieta, Ontario and Carlsbad) executed a series of clinical and basic science trials to document the safety and efficacy of the monoclonal antibody therapy that triggers the immune system to kill the T cell lymphoma cancer cells ...
Vet Tech Week!
Oct 17, 2014
In honor on National Veterinary Technician Week, CVS would like to thank each and every one of our dedicated technicians for their hard work, compassionate care and invaluable service to the veterinary field. Pictured are a few of our wonderful technicians from all three hospitals.